Xiaojun Tian

Peking University

Papers

1

Total Citations

11

H-Index

1

About

Xiaojun Tian is a leading urologic surgeon and researcher whose work centers on advancing robotic surgery, particularly for complex oncologic procedures. His major contributions lie in rigorously evaluating emerging surgical platforms to improve patient outcomes. In a landmark multicenter prospective randomized controlled trial, Tian compared the novel KangDuo Surgical Robot-01 System against the established da Vinci System for robot-assisted radical nephroureterectomy. This pivotal study, published in 2024 and already garnering 11 citations, demonstrated the safety and effectiveness of the KangDuo system, offering crucial evidence for expanding access to robotic surgery. By systematically validating new technologies, Tian is helping to shape the future of minimally invasive urologic oncology. His research not only informs clinical practice but also drives innovation in surgical robotics, making him a key figure in the field. Through his rigorous comparative studies, Tian is directly contributing to the global effort to make advanced surgical care more accessible and affordable.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted radical nephroureterectomy using the KangDuo Surgical Robot-01 System versus the da Vinci System: a multicenter prospective randomized controlled trial
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Peking University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago